Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Alveus Therapeutics is a clinical-stage biotech company developing therapies for obesity and metabolic diseases.
InduPro deevlops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease.
Enable Injections develops and manufactures wearable drug delivery systems centered on the enFuse platform.
Rology is an AI-assisted On-demand Teleradiology Platform.
Lifordi Immunotherapeutics is a biotech company that provides antibody-drug conjugates for autoimmune and inflammatory disorders.
Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.
Electra Therapeutics is a clinical-stage biotechnology company developing antibody therapies for immunological diseases and cancer.
Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases.
Quant Health offers drug simulation, computational biology, clinical data science, respiratory, trial simulation, and oncology services.
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
Enveda Biosciences is a biotechnology company that develops novel medications derived from plants.
MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
Kasha delivers pharmaceutical products and household goods to low-income consumers, resellers, pharmacies, and health facilities.
Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies.
Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.
Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.
Eligobiotics provides a new approach to explore, understand, and control bacterial ecosystems both in human and animals.
Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.
Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.
Glycomine is an early-stage biotech working on replacement therapies for rare diseases.
AdvanCell is a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer treatment.
Click Therapeutics develops software as a medical treatment prescription platform designed to deliver digital treatments for patients.
Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.
Genetix Biotherapeutics develops and delivers approved gene therapies for severe rare genetic diseases like sickle cell.
Sanofi has invested in 131 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sanofi's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Medical. The firm invests across 25 different industry categories.
Among tracked funding rounds, MapLight Therapeutics received $372.5M in a Series D round. Sanofi's total known invested capital is $6.2B.
Sanofi's average investment size is $117.1M across its portfolio of 131 companies.
Recent Sanofi portfolio additions include Alveus Therapeutics, InduPro, Enable Injections, Rology, Lifordi Immunotherapeutics. These companies were founded in 2020 or later.